This Stock Grew 135% Last Year and Is Down 50% From Its Highs
Is Fulgent an underrated stock or a value trap?
Stay updated with breaking news from Inform Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Is Fulgent an underrated stock or a value trap?
/PRNewswire/ -- Avista Capital Partners ("Avista"), a leading private equity firm focused exclusively on healthcare, today announced that it has closed on the...
/PRNewswire/ -- Avista Capital Partners ("Avista"), a leading private equity firm focused exclusively on healthcare, today announced that it has closed on the...
Plus C-suite changes for TimelyMD and Medical City Plano's burn unit verification.
Learn more about Fulgent Genetics’ agreement to buy Texas testing firm Inform Diagnostics for $170 million, boosting its non-Covid testing business.